Patrick Machado

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Aneta Fergson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Patrick Machado:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Arcus Biosciences, Inc. Director Common Stock 38.6K $313K $8.12 10 Jun 2025 Direct
ALUMIS INC. Director Common Stock 7.06K $30.6K $4.33 21 May 2025 By Trust
ACELYRIN, Inc. Director Common Stock 0 $0 $2.45 21 May 2025 Indirect
Adverum Biotechnologies, Inc. Director Common Stock 0 $0 $4.26 09 Dec 2025 Direct
CHIMERIX INC Director Stock Option (Right to Buy) 60K 09 Jun 2023 Direct
ALUMIS INC. Director Stock Option (Right to Buy) 49.8K 30 Jul 2025 Direct
Arcus Biosciences, Inc. Director Stock Option (Right to Buy) 38.3K 10 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Share Option (Right to Buy) 17K 05 Jun 2025 Direct
Xenon Pharmaceuticals Inc. Director Restricted Share Units 2.65K 05 Jun 2025 Direct
ACELYRIN, Inc. Director Director Stock Option (right to buy) 0 21 May 2025 Direct
Adverum Biotechnologies, Inc. Director Stock Option (Right to Buy) 0 09 Dec 2025 Direct
Turning Point Therapeutics, Inc. Director Stock Option (right to buy) 0 17 Aug 2022 Direct

Insider Reports Filed by Patrick Machado

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ADVM Adverum Biotechnologies, Inc. 09 Dec 2025 13 $0 4 Director 10 Dec 2025, 13:22
ALMS ALUMIS INC. 30 Jul 2025 1 $0 4 Director 01 Aug 2025, 16:05
ADVM Adverum Biotechnologies, Inc. 17 Jun 2025 2 $0 4 Director 20 Jun 2025, 16:21
RCUS Arcus Biosciences, Inc. 10 Jun 2025 2 $0 4 Director 12 Jun 2025, 16:28
XENE Xenon Pharmaceuticals Inc. 05 Jun 2025 2 $0 4 Director 06 Jun 2025, 18:00
SLRN ACELYRIN, Inc. 21 May 2025 6 $0 4 Director 23 May 2025, 16:06
ALMS ALUMIS INC. 21 May 2025 6 $0 4 Director 23 May 2025, 16:05
ALMS ALUMIS INC. 27 Jun 2024 3 $0 4 Director 01 Jul 2024, 16:41
ALMS ALUMIS INC. 27 Jun 2024 0 $0 3 Director 27 Jun 2024, 16:09
ADVM Adverum Biotechnologies, Inc. 17 Jun 2024 2 $0 4 Director 20 Jun 2024, 16:43
SLRN ACELYRIN, Inc. 07 Jun 2024 1 $0 4 Director 11 Jun 2024, 19:09
RCUS Arcus Biosciences, Inc. 06 Jun 2024 2 $0 4 Director 07 Jun 2024, 18:20
XENE Xenon Pharmaceuticals Inc. 05 Jun 2024 1 $0 4 Director 05 Jun 2024, 17:42
SLRN ACELYRIN, Inc. 04 Oct 2023 1 $0 4 Director 06 Oct 2023, 17:56
TSBX Turnstone Biologics Corp. 20 Jul 2023 0 $0 3 Director 20 Jul 2023, 21:52
RCUS Arcus Biosciences, Inc. 15 Jun 2023 2 $0 4 Director 16 Jun 2023, 20:05
ADVM Adverum Biotechnologies, Inc. 09 Jun 2023 2 $0 4 Director 13 Jun 2023, 17:02
CMRX CHIMERIX INC 09 Jun 2023 1 $0 4 Director 12 Jun 2023, 16:28
XENE Xenon Pharmaceuticals Inc. 02 Jun 2023 1 $0 4 Director 02 Jun 2023, 17:20
SLRN ACELYRIN, Inc. 09 May 2023 8 $0 4 Director 11 May 2023, 21:09
SLRN ACELYRIN, Inc. 04 May 2023 1 $0 4 Director 04 May 2023, 20:16
SLRN ACELYRIN, Inc. 04 May 2023 0 $0 3 Director 04 May 2023, 19:47
TPTX Turning Point Therapeutics, Inc. 17 Aug 2022 3 $0 4 Director 17 Aug 2022, 16:41
XENE Xenon Pharmaceuticals Inc. 28 Jun 2022 1 $0 4 Director 29 Jun 2022, 17:34
CMRX CHIMERIX INC 23 Jun 2022 1 $0 4 Director 24 Jun 2022, 11:10
RCUS Arcus Biosciences, Inc. 14 Jun 2022 2 $0 4 Director 16 Jun 2022, 16:26
ADVM Adverum Biotechnologies, Inc. 10 Jun 2022 2 $0 4 Director 14 Jun 2022, 16:19
ROIV Roivant Sciences Ltd. 01 Oct 2021 0 $0 3 Director 01 Oct 2021, 17:43
CMRX CHIMERIX INC 23 Jun 2021 1 $0 4 Director 25 Jun 2021, 17:24
RCUS Arcus Biosciences, Inc. 03 Jun 2021 2 $0 4 Director 07 Jun 2021, 16:40
XENE Xenon Pharmaceuticals Inc. 03 Jun 2021 1 $0 4 Director 03 Jun 2021, 21:09
TPTX Turning Point Therapeutics, Inc. 02 Jun 2021 1 $0 4 Director 04 Jun 2021, 17:41
ADVM Adverum Biotechnologies, Inc. 12 May 2021 2 $0 4 Director 14 May 2021, 20:01